I now have everything needed. Here is the complete, simplified explanation with flowcharts.
Nucleotide Metabolism - Simplified
What is a Nucleotide?
A nucleotide = Base + Sugar + Phosphate(s)
| Component | Options |
|---|
| Base | Purine (A, G) or Pyrimidine (C, T, U) |
| Sugar | Ribose (RNA) or Deoxyribose (DNA) |
| Phosphate | 1, 2, or 3 groups |
The Big Picture - Nucleotide Metabolism Has 3 Parts
NUCLEOTIDE METABOLISM
│
┌────┴─────┐
│ │
PURINES PYRIMIDINES
(A, G) (C, T, U)
│ │
└────┬─────┘
│
Each has 3 fates:
┌────┴──────┬──────────┐
│ │ │
DE NOVO SALVAGE DEGRADATION
SYNTHESIS PATHWAY (breakdown)
(build (recycle (waste
from old bases) products)
scratch)
PART 1 - PURINE METABOLISM
Purine Bases: Adenine (A) and Guanine (G)
A. De Novo Synthesis (Building from Scratch)
Ribose-5-phosphate (from pentose phosphate pathway)
│
▼ (activated by PRPP synthetase)
PRPP
(5-phosphoribosyl-1-pyrophosphate)
│
▼ ← Glutamine donates N
│ [REGULATED STEP - enzyme: GPAT]
│ inhibited by AMP & GMP (end-products)
▼
5-Phosphoribosylamine
│
▼ (10 more enzymatic steps
│ atoms come from: Glycine, Glutamine,
│ CO₂, Aspartate, Folate/THF)
▼
IMP ← (Inosine Monophosphate = branch point)
┌──┴──┐
▼ ▼
AMP GMP
│ │
▼ ▼
ADP GDP
│ │
▼ ▼
ATP GTP ← Used in RNA synthesis
B. Salvage Pathway (Recycling Old Bases)
Free purine bases (from cell turnover / diet)
│
▼ + PRPP
HGPRT enzyme → Hypoxanthine → IMP → AMP/GMP
APRT enzyme → Adenine → AMP
[HGPRT deficiency = Lesch-Nyhan Syndrome]
(self-mutilation, hyperuricemia, gout)
C. Purine Degradation
AMP → Adenosine → Inosine → Hypoxanthine
GMP → Guanosine → Guanine → Xanthine
│
▼ (xanthine oxidase - XO)
XANTHINE
│
▼ (xanthine oxidase - XO)
URIC ACID
(final waste product)
│
┌─────────┴─────────┐
▼ ▼
Excreted in urine ↑ Uric acid = GOUT
(normal) (MSU crystal deposits)
[Allopurinol inhibits XO → treats gout]
PART 2 - PYRIMIDINE METABOLISM
Pyrimidine Bases: Cytosine (C), Uracil (U), Thymine (T)
A. De Novo Synthesis
Key difference from purines: the ring is built BEFORE being attached to ribose
CO₂ + Glutamine + ATP
│
▼ [REGULATED STEP - enzyme: CPS II]
│ Inhibited by UTP (end-product)
│ Activated by PRPP
▼
Carbamoyl Phosphate
│
▼ + Aspartate
Carbamoyl Aspartate
│
▼
Dihydroorotate
│
▼
Orotate
│
▼ + PRPP (now attached to ribose)
OMP (Orotidine 5'-monophosphate)
│
▼
UMP (Uridine monophosphate)
│
┌─────┴──────┐
▼ ▼
UTP dUMP
│ │ (thymidylate synthase + folate/THF)
▼ ▼
CTP dTMP ← needed for DNA only
Note: UMP synthase deficiency = Orotic Aciduria (orotic acid builds up in urine)
PART 3 - DEOXYRIBONUCLEOTIDE SYNTHESIS
All deoxyribonucleotides (for DNA) come from reducing ribonucleotides:
Ribonucleoside diphosphates (ADP, GDP, CDP, UDP)
│
▼ [Ribonucleotide reductase - RNR]
│ NADPH provides reducing power (via Thioredoxin)
│ Strongly inhibited by dATP
▼
Deoxyribonucleoside diphosphates (dADP, dGDP, dCDP, dUDP)
│
▼
Used in DNA synthesis
[Hydroxyurea inhibits RNR → anticancer drug]
Master Overview Flowchart
DIETARY NUCLEOTIDES (mostly degraded in GI tract)
│
▼
┌────────────────────────────────────┐
│ CELL MAKES NUCLEOTIDES │
│ via 2 routes: │
│ 1. DE NOVO (from amino acids, │
│ CO₂, folate, ribose-5-P) │
│ 2. SALVAGE (recycle old bases) │
└────────────────────────────────────┘
│
┌───────┴────────┐
▼ ▼
PURINES PYRIMIDINES
(IMP → AMP/GMP) (OMP → UMP → UTP/CTP)
│ │
└───────┬─────────┘
▼
RIBONUCLEOTIDES (NTPs)
→ Used in RNA synthesis
→ Used as energy (ATP)
→ Signal molecules (cAMP, cGMP)
│
▼ [Ribonucleotide reductase]
DEOXYRIBONUCLEOTIDES (dNTPs)
→ Used in DNA synthesis
│
┌───────┴────────┐
▼ ▼
PURINES PYRIMIDINES
degraded to degraded to
URIC ACID CO₂ + NH₃
(excreted) (easily cleared)
Key Concept Map (from Lippincott's Biochemistry)
Quick Summary Table
| Feature | Purines (A, G) | Pyrimidines (C, U, T) |
|---|
| Ring built | On ribose (PRPP first) | Off ribose, then attached |
| Regulated step | GPAT (inhibited by AMP, GMP) | CPS II (inhibited by UTP) |
| Activated by | PRPP | PRPP |
| Salvage enzyme | HGPRT / APRT | Not prominent |
| Degradation product | Uric acid | CO₂ + NH₃ |
| Key disease | Gout, Lesch-Nyhan | Orotic aciduria |
Key Drugs That Target Nucleotide Metabolism
| Drug | Target | Use |
|---|
| Allopurinol | Xanthine oxidase | Gout |
| Hydroxyurea | Ribonucleotide reductase | Cancer, sickle cell |
| Methotrexate | Dihydrofolate reductase (blocks THF for TMP synthesis) | Cancer, autoimmune |
| 5-Fluorouracil | Thymidylate synthase (blocks dTMP) | Cancer |
| Sulfonamides | Folate synthesis in bacteria | Antibacterial |
Source: Biochemistry, 8th ed. Lippincott Illustrated Reviews, Chapter 22